Lund Melanoma Study Group
141 – 150 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
ASO Author Reflections : Effects of the Updated AJCC Classification for Patients with Stage III Melanoma
- Contribution to journal › Debate/Note/Editorial
-
Mark
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm : long-term follow-up of a multicentre, randomised trial
- Contribution to journal › Article
-
Mark
Curative therapy in cancer- a perspective
- Contribution to journal › Article
-
Mark
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
- Contribution to journal › Article
-
Mark
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
- Contribution to journal › Article
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
- Contribution to journal › Article
-
Mark
Physical activity and survival following breast cancer
- Contribution to journal › Article
-
Mark
Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
- Contribution to journal › Article
-
Mark
Risk factors for subarachnoid haemorrhage : a nationwide cohort of 950 000 adults
- Contribution to journal › Article
